Jennifer L Taubert insider trades: Johnson & Johnson (JNJ) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jennifer reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | JNJ | ↓ Sell | 15,000 | $263.36 | $4.0M | Direct | Aug 18, 2026 (1d) |
| Sep 4, 2025 | JNJ | ↓ Sell | 56,471 | $177.81 | $10.0M | Direct | Sep 5, 2025 (1d) |
| Feb 9, 2024 | JNJ | ↓ Sell | 59,397 | $156.27 | $9.3M | Direct | Feb 12, 2024 (3d) |
| Nov 22, 2022 | JNJ | ↓ Sell | 76,923 | $176.78 | $13.6M | Direct | Nov 23, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other JNJ insiders
Open-market trades in the last 12 months
About Jennifer L Taubert's insider trades
Jennifer L Taubert is EVP, WWC. Innovative Medicine at Johnson & Johnson (JNJ). Since Nov 22, 2022, Jennifer has reported no open-market purchases and 4 sales worth $36.9M on SEC Form 4. In the last 12 months: 1 sale ($4.0M).
Their filings also include grants and awards (25 filings), option exercises (16 filings), shares withheld for taxes (14 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every JNJ insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.